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Background: Integrins are plasma membrane proteins
that mediate adhesion to other cells and to components of
the extracellular matrix. Most integrins are constitutively
inactive in resting cells, but are rapidly and reversibly acti-
vated in response to agonists, leading to highly regulated
cell adhesion. This activation is associated with conforma-
tional changes in their extracellular portions, but the nature
of the structural changes that lead to a change in adhesive-
ness is not understood. The interactions of several integrins
with their extracellular ligands are mediated by an A-type
domain (generally called the I-domain in integrins). Bind-
ing of the I-domain to protein ligands is dependent on
divalent cations. We have described previously the struc-
ture of the I-domain from complement receptor 3 with
bound Mg2+, in which the glutamate side chain from a
second I-domain completes the octahedral coordination
sphere of the metal, acting as a ligand mimetic.
Results: We now describe a new crystal form of the
I-domain with bound Mn 2+ , in which water completes
the metal coordination sphere and there is no equivalent of
the glutamate ligand. Comparison of the two crystal forms
reveals a change in metal coordination which is linked to a
large (10 A) shift of the C-terminal helix and the burial of
two phenylalanine residues into the hydrophobic core of
the Mn2+ form. These structural changes, analogous to
those seen in the signal-transducing G-proteins, alter the
electrophilicity of the metal, reducing its ability to bind
ligand-associated acidic residues, and dramatically alter the
surface of the protein implicated in binding ligand.
Conclusions: Our observations provide the first atomic
resolution view of conformational changes in an integrin
domain, and suggest how these changes are linked to a
change in integrin adhesiveness. We propose that the
Mg'2 form represents the conformation of the domain in
the active state and the Mn 2+ form the conformation in
the inactive state of the integrin.
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Introduction
The integrin family of cell-adhesion molecules are ota
heterodimers with a generally conserved structure [1]. So
far, 16 distinct ot subunits (with -1000 residues) have
*been identified that pair with eight different 3 subunits
(-750 residues). Electron microscopy indicates that inte-
grins have an extracellular globular 'head' (-100 A diam-
eter) comprising the N-terminal portion of both
subunits, followed by a long 'stalk' (-100 A) between the
globular head and the membrane-spanning helices, and a
short C-terminal cytoplasmic 'tail' for each subunit.
Biochemical and biophysical probes have shown that
activation of integrins to an adhesion-promoting state
involves conformational changes in the extracellular
domains. Thus, fluorescence energy transfer experiments
show that the integrin ollb[3 changes shape on activation
[2], and there is also a marked change in proteolytic
sensitivity, consistent with a change of shape and/or
rigidity [3]. Furthermore, monoclonal antibodies have
been described that discriminate between active and
inactive states (reviewed in [4-6]). Allostery within the
extracellular domains has been vividly demonstrated by
electron miscroscopic images of integrins with both
activating antibodies and ligands bound, separated
by a distance of 160 A [7]. However, the nature of
the conformational changes that lead to a change in
adhesiveness is not known.
Seven integrin oa subunits contain a -190-residue
sequence near their N terminus that is homologous to
the A-domains of von Willebrand factor, and is generally
called the I-domain in integrins. This domain plays a
major role in ligand binding [8-14], and undergoes con-
formational changes in response to receptor activation
[14-16]. We have previously proposed that a conserved
region found in all B subunits, and implicated in ligand
binding, also adopts an A-type fold [17].
The 32 integrins are a subfamily of integrins found
exclusively on leukocytes [18]. One of them, com-
plement receptor 3 (CR3; also known as CDllb/CD18,
OtMf or Mac-1), is the major integrin of phagocytic
cells, and is required for phagocytosis and the stable adhe-
sion of leukocytes to endothelium and the subsequent
migration into inflamed organs. These functions are
mediated through binding to several physiologic ligands
including iC3b (the major complement C3 opsonin),
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ICAM-1 (CD54), and the coagulation factor fibrinogen.
The recombinant I-domain from CR3 has many of the
binding functions of the intact receptor, and ligand bind-
ing is dependent on divalent cations. We have previously
determined its structure from crystals grown in the pres-
ence of Mg2 + [17]. It adopts a classic 'dinucleotide-bind-
ing' or 'Rossmann' fold, and contains an unusual Mg2 +
coordination site at its surface, which we call the metal-
ion-dependent adhesion site (MIDAS) motif. Point
mutations in the MIDAS motif abrogate cation binding
and binding to many protein ligands [8-10,17]. In the
Mg2+-containing I-domain crystal, one of the coordinat-
ing ligands is the glutamate side chain from another
I-domain molecule, and we have proposed that this inter-
action is a mimic of a natural integrin-ligand interaction,
because all known integrin ligands contain acidic residues
as a key feature of their binding motifs [19].
Here we describe a new crystal form of the I-domain,
grown in the presence of Mn2 +, in which the domain
is 'unliganded', and compare it with the previously
described 'liganded' structure grown in the presence
of Mg2 +. The two structures display large differences,
and we propose that they represent the conformations of
the domain that exist in the active and inactive states of
the integrin.
Results and discussion
Two crystal structures of the I-domain
The I-domain adopts the dinucleotide-binding or
Rossmann fold, with seven x helices (labelled al-a7)
surrounding a mostly parallel 3 sheet (labelled 3A-[3F;
Fig. la). The MIDAS motif is located in a crevice at the
top of the sheet. The motif, conserved in many members
of the A-domain superfamily, comprises a DxSxS
sequence (residues 140-144; single-letter code; where x is
any amino acid) from the 1A-al loop, Thr209 from the
a3--4 loop and Asp242 from the [D-ra5 loop. Crystal-
lization of the domain in a minimal concentration of
Mn2 + produced a crystal form different from that previ-
ously obtained in an excess of Mg2+ [17]. We determined
the Mn2 + I-domain structure by molecular replacement
and refined the model at 2.0 A resolution (Fig. lb). About
two-thirds of the molecule has a very similar structure in
both crystal forms: the central 3 sheet (except for 3F) and
the a helices (except for cal, ao6 and 7) can be closely
superimposed; residues 132-140, 167-241 and 245-265
overlap with a root mean square (rms) difference for
main-chain atoms of 0.46 A (Fig. 2a), and the two crystal
forms are compared in this reference frame.
The metal coordination is different in the two structures.
In the Mg2+ form (Fig. 3a), two serines and a threonine
Fig. 1. (a) Primary sequence of the CR3
I-domain, with secondary structure
assignments. Residue numbering is
according to the intact protein. MIDAS
residues are shown in bold. Lower-case
letters denote residues invisible in the
electron-density map. The last six
residues are derived from the cloning
vector. (b) Stereo electron-density map
(2Fo-F c) of the Mn2+ coordination site,
contoured at 1.7a. The two phenylala-
nine residues (F275 and F302) which
become buried in the Mn2+ form are
shown. Water molecules are indicated
by crosses. For clarity, only density
within 2 A of the selected atoms is
displayed.
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Fig. 2. (a) Rms difference by residue (main chain) between Mg2+ and Mn2+ I-domains. (Domains were superimposed on residues
132-140, 167-241 and 245-265 with an rms difference of 0.46 A.) Secondary structure elements for the Mn2+ form are indicated
along the horizontal axis. The positions of crystal contacts (interatomic distances <4 A) for Mg 2 + (open triangles) and Mn2+ (filled trian-
gles) forms are also marked. (b) Comparison of main-chain temperature factors in the Mg2+ (thick line) and Mn2 + (thin line) I-domains.
make strong bonds to the metal via their side-chain
hydroxyl oxygen atoms (bond lengths 2.0±0.1 A); two
water molecules also bind directly to the metal, and two
aspartates make indirect contacts via water molecules.
The absence of direct bonds between Mg 2+ and the neg-
atively charged aspartate ligands enhances the elec-
trophilicity of the metal, and, in the crystal, the side
chain of a glutamate residue from a neighbouring mol-
ecule completes the coordination; that is, the Mg2 +
I-domain is liganded. In the Mn2+ form (Fig. 3b), the
metal moves by 2.3 A; bonds are made to the two ser-
ines, as before, but the bond to Thr209 is broken and
replaced by a direct bond to Asp242, reducing the elec-
trophilicity of the metal. Water molecules complete the
coordination sphere, and there is no equivalent of the
exogenous glutamate (the nearest acidic side chain from
another molecule is 9 A away); that is, the Mn 2+
I-domain appears to be unliganded.
The change in metal coordination is linked to structural
changes in the protein (Figs 3c,d and 4). In the Mn2 +
form, the C-terminal helix, ot7, moves 10 A up the side
of the molecule. This requires a repacking of the
hydrophobic face of a7 against the side of the domain; the
helix extends by an extra turn at its C terminus and bends
in the middle, wrapping around the hydrophobic core. At
the N terminus of a7, Phe302, which was completely
exposed in the Mg2+ form, inserts into the top of the
domain. Burial of this phenylalanine causes shifts in three
loops and their connecting strands and helices which dis-
rupt the MIDAS motif. First, the 3A-a 1 loop, which
includes the DxSxS sequence, shifts so that Ser144 moves
1.5 A further away from Thr209, making it impossible for
a metal ion to bridge both residues. Second, the 3E-oa6
loop, which packed against the 3A-otl loop in the Mg2 +
form, shifts by 1.5 A, and rearrangements occur that bury
a second phenylalanine (Phe275). Third, Phe275 packs
against the D-a5 loop, which flips so that the carbonyl
of Gly243 rotates by 1800 and its Cot moves by 4 A; the
Cot of Asp242 moves by 2.5 A so that its side chain can
make a direct bond to the metal.
The temperature factors (B values) are, as expected, low
for the helices and strands, and higher for some of the
loops, particularly the aol-PB, a4-3D and 3E-6 loops
(Fig. 2b). The B values are generally well conserved
between the two structures, despite the different crystal
contacts and large structural changes. The C-terminal
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Fig. 3. Structural comparisons of the
Mg2 + and Mn2 + I-domains. (a) The
MIDAS motif in the Mg2+ form. (b) The
MIDAS motif in the Mn2+ form. The
colour code is oxygen atoms (red), car-
bon (black), schematic backbone (grey)
and the glutamate from a neighbouring
molecule (gold). Water molecules are
labelled wl-w3. Selected hydrogen
bonds are shown as dashed red lines.
(c) Stereo Ca plot comparing Mg2+ (red)
and Mn2 + (blue) I-domains. Regions of
large change are shown with thicker
lines. The metal ions are shown as
spheres. The N and C termini and occa-
sional residues are labelled. (d) Stereo
close-up comparison of the Mg2+ (red)
and the Mn2+ (blue) forms: C plot,
together with selected side chains
(metal-coordinating residues and the
two buried phenylalanines), and the
main chain for residues 242-243.
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GTP-bound ('active') form of p21ras a Mg2 + ion binds
directly to a serine, a threonine and two water molecules,
and indirectly to an aspartate; the other coordination sites
are filled by the - and y-phosphate oxygen atoms of the
GTP. On hydrolysis of the GTP and loss of the y-phos-
phate, the Mg2+ switches its coordination so that the
bond to the threonine is lost and a direct bond to the
aspartate is gained (Fig. 5). The changes in metal coordi-
nation cause large changes in the effector region which
bury a previously exposed isoleucine residue and switch
the molecule from an active to an inactive state. Thus,
the inactive conformer of p21 ras is characterized
by reduced electrophilicity of the metal (i.e. direct co-
ordination of an aspartate residue) and the burial of a
hydrophobic residue.
Fig. 4. Schematic diagram of the Mn2+ I-domain (grey). Major
conformational differences are shown in red (Mg2+) and blue
(Mn2+). 3 strands are labelled A-F and helices 1-7.
helix, oa7, is equally well ordered in the two structures,
although the 3E-a6 loop is more mobile in the Mn2 +
form. Crystal contacts are quite evenly distributed across
the surface of both crystal forms (Fig. 2a). The oa7 helix
in the Mg2 + structure is involved in two major contacts
centred around Phe302 and Glu314, so it is possible that
crystal contacts play a role in determining the position of
this helix.
Structural determinants of activation
These changes in metal coordination and associated pro-
tein movements have a striking parallel in the signal-
transducing G-proteins [2 0- 2 3 ]. For example, in the
Is an analogous pathway of activation operating in the
I-domain? In the absence of exogenous ligand, we suggest
that the Mn 2+ form is thermodynamically favoured,
owing to the burial of hydrophobic residues into the core
of the protein, and that this conformation represents the
inactive state. In the Mg2 + crystals, ligand binding (in this
case provided by another I-domain molecule) and the for-
mation of a strong bond to Thr209 provide enough
energy to expel two phenylalanines from the hydrophobic
core, and we suggest that this structure represents the
active state. The existence of two distinct conformations
is consistent with the ability of certain antibodies (that
recognize epitopes on the I-domain) to discriminate
between active and inactive states of the integrin [14-16].
Furthermore, the large shift of the C-terminal helix in the
context of the whole integrin may radically alter the
accessibility of the domain to both antibodies and protein
ligands. Recent studies have shown that the ligand-bind-
ing surface is not limited to the MIDAS motif, but
extends across the upper surface of the domain ([24];
P Rieu, T Sugimori and MA Arnaout, unpublished data).
Indeed, the two structures have quite different surface
appearances, which should provide further control of lig-
and affinity: for example, an acidic pocket evident in the
Mg2+ form is largely obscured in the Mn2+ form (Fig. 6).
Fig. 5. Comparison of structural changes
in (a) the MIDAS motif and (b) the
p21 ra-GTP complex. Movements of the
metal-coordinating residues are indi-
cated (see text).
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Fig. 6. Solvent-accessible surface of
(a) the Mg2+ and (b) the Mn2+ I-domain,
with surface charge calculated by
GRASP [39]: negatively charged regions
in red, positive in blue. The view is
perpendicular to that shown in Figure 4.
Binding of ligands to the recombinant I-domain in vitro is
supported by both Mn2 + and Mg2+ , but not by Ca2+
[9,25], recapitulating the behaviour of the intact integrin
[8,26]. In vivo, Mg2+ is likely to be the cation providing
the integrin-ligand bridge, because of its high concentra-
tion (-1 mM) in plasma. Our model suggests why Ca2+
cannot support ligand binding. The chemistry of Ca2+ is
mostly ionic and it prefers negatively charged ligands,
whereas Mg2+ and Mn2 + are smaller ions with a greater
tendency to form covalent bonds [27]. Mg2+ and Mn2 +
can be stably coordinated by uncharged serine and thre-
onines residues, but Ca 2+ cannot be thus ligated. Ca2 +
should therefore prefer, and at high concentrations stabi-
lize, the inactive conformation, in which an aspartate is
directly coordinated instead of a threonine.
Our assignment of the Mn2 + crystal form as the inactive
conformation appears at first sight surprising, as Mn 2+ is
well known as an activator of integrins in vitro [28]. We
cannot provide a simple explanation for the apparent
crystallization of the Mn2 + I-domain in an inactive form,
but it should be pointed out that the binding affinities of
active and inactive integrins for monomeric ligands differ
typically by one order of magnitude (-1.5-2 kcal mol-1),
so that the difference in energy between the two
I-domain conformations is likely to be small compared
with typical crystal lattice energies. There are differences
in metal concentrations and temperature which could
explain the different crystal forms (see the Materials and
methods section), and we also note that in crystals of a
homologous I-domain from CDlla/CD18 (LFA-1), the
molecule adopts the inactive Mn 2+ conformation
described here (with the MIDAS motif unliganded),
whether grown in the presence of Mg2+ or Mn2+ (our
unpublished data). This shows that the metal ion is not
the sole determinant of the protein conformation, and
suggests that the two conformations described in this
paper represent two 'snapshots' of a dynamic equilibrium
existing in solution. Clearly, further biochemical studies
are required to test our proposal directly.
Our structural data suggest that the I-domain can exist in
two distinct tertiary forms, a high-affinity state and a
low-affinity state. Because the isolated I-domain binds
ligands constitutively [8], quaternary constraints must be
present in the intact o3 integrin that hold the domain in
the inactive state in the absence of an activation signal
[29]. We do not yet know how the tertiary changes
we have described are linked to the quaternary changes
that occur on integrin activation, but their magnitude
and character are reminiscent of those found in other
well-studied allosteric systems [30].
Biological implications
Integrins are plasma membrane proteins that
mediate adhesion to other cells and to components
of the extracellular matrix. Integrin-mediated cell
adhesion is regulated by intracellular signals that
lead to conformational changes in the extracellular
domains of these receptors. This property is essen-
tial both in development and in many functions of
the immune system, but its structural basis is
unknown. Integrins are ajL heterodimers with a
generally conserved structure. The A-domain (or
I-domain) is a -190-residue extracellular fragment
from the al subunit of certain integrins that has
many of the ligand-binding properties of the intact
receptor. Our structural studies of this domain
reveal two distinct conformations, in which a
change in metal coordination is linked to large
conformational changes in the protein. These
changes cause a dramatic alteration in the surface
of the protein implicated in binding ligand, sug-
gesting that they are linked to a change in adhesive-
ness. The two conformations described here have
parallels with those observed in the signal-trans-
ducing G-proteins, and we propose, by analogy,
that they represent the structure of the I-domain in
the active and inactive states of the integrin.
In integrins that do not contain an a subunit
I-domain, a conserved region in the subunit has
been implicated in ligand binding and activation
[4]. The region contains part of the metal-binding
consensus sequence (DxSxS), and we have previ-
ously proposed, based on hydropathy plots, that
this conserved region also adopts an I-domain
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fold [17]. If this is the case, then it too may
undergo structural transformations of the kind
described here.
The extensive biochemical data on integrins indi-
cate that these cell-adhesion molecules exist pri-
marily in one of two states: active and inactive.
Our results show that the I-domain can exist in
two distinct tertiary states, and it is tempting to
suggest a two-state allosteric model of integrin
activation [31]. In such a model, the integrin is in
equilibrium between a low-affinity quaternary
state (inactive, 'T' state) and a high-affinity qua-
ternary state (active, 'R' state). The T state is
more stable in the absence of ligand or activation
signal (owing to the burial of hydrophobic
groups), but the R state has a higher affinity for
ligand (owing to increased electrophilicity of the
metal and the presence of a complementary lig-
and-binding surface). The tertiary and quaternary
states are linked, so that each quaternary state is
associated with a unique set of stable tertiary
states, 't' and 'r'. What are the available data?
First, binding of monoclonal antibodies to regions
of the aL or fB subunit not directly involved in
binding ligand can activate integrins [4]. In a two-
state model, these antibodies preferentially bind to
and stabilize the 'r' tertiary state of an integrin
domain (i.e. the conformation of that domain in
the R quaternary state), which shifts the quater-
nary equilibrium towards the R state, in which the
tertiary state of the ligand-binding domain is in
the high-affinity 'r' conformation. Second, muta-
tions in subunits that are not directly implicated
in ligand binding can have dramatic effects on
integrin-ligand interactions. For example, a point
mutation in the conserved region of the [3 subunit
abolishes adhesion to physiological ligands, even
though the major binding site for these ligands is
located on the ae subunit [32,33]. In a two-state
model, the mutation locks the -conserved region
into the 't' state and thus shifts the quaternary
equilibrium of the integrin towards the T state, in
which the a subunit I-domain is in the 't' confor-
mation. Finally, the exquisite sensitivity of inte-
grins to even conservative mutations [34] is
reminiscent of other well-studied allosteric sys-
tems, where point mutations can radically alter
the equilibrium between the T and R states [30].
Materials and methods
Crystallization
Recombinant CD1 lb I-domain was expressed and purified as
described previously [17]. Crystals of the Mn2+ form grow
overnight by sitting-drop vapour-equilibration of protein
(12 mg ml- ) against 14% PEG 3350, 0.1 M Tris pH 8.5,
10 mM -mercaptoethanol, 1 mM MnC12 (initial) at 4C.
Crystals grow in the monoclinic space group C2, with
a=135 A, b=37.1 A, c=38.5 A, =92.6° . Under the alkaline
conditions used, most of the unchelated Mn 2+ oxidizes and
precipitates (as MnO2) within a few hours. The final concen-
tration of Mn 2+ ion in the crystallization drop was estimated
with the dye Eriochrome Black T (Sigma Chemical Co., St
Louis, MO), and found to be equimolar with the protein; rins-
ing the crystals in fresh Mn 2+ solution prior to data collection
ensured full metal occupancy. Most other metals, with the
exception of Mg2+, are unstable or precipitate under the alka-
line conditions required for crystal growth. Crystals of the
Mg2+ form grow under very similar conditions: 12% PEG
8000, 0.1 M Tris pH 8.5, 1 mM MgC1 2, 10 mM -mercap-
toethanol at room temperature, and belong to the tetragonal
space group P43 with unit cell dimensions a=45.7 A, c=94.3 A
[17]. Crystals do not grow in the absence of metal.
Data collection and refinement
A Mn 2+ I-domain crystal was transferred briefly into a freshly
prepared solution containing 14% PEG 3350, 0.1 M Tris
pH 8.5, 1 mM MnC12, 30% glycerol, and immediately frozen
in a nitrogen stream at 100 K prior to data collection. Data
were collected to 2.0 A resolution on beam line X12C of the
National Synchrotron Light Source at the Brookhaven
National Laboratory using a MarResearch imaging plate, with a
wavelength of 0.98 A. Data were processed with DENZO and
SCALEPACK [35] to an Rym of 6% (27% in outer shell) and
the data are 99.5% complete (12 933 unique reflections; average
redundancy 3.6). The structure was solved with the molecular
replacement program AMoRe [36] using the Mg2+ structure as
the search model [17]. The rotational and translational search
gave one obvious solution with an initial R-factor of 45%. The
structure was refined using X-PLOR [37] and manual model
building into omit maps [38]. The metal ion was not included
in the initial refinement, which converged at an R-factor of
30%. Many regions of the protein had poor or discontinuous
electron density at this stage, especially around the MIDAS
motif and helix a7. A peak in the Fo-F c map at the presumed
location of the metal was no stronger than a water molecule
peak, but inclusion of a Mn2+ ion into the model dramatically
improved both the electron density for the MIDAS motif and
the overall appearance of the map; the new position of the
helix a7 also became clear in an Fo-F c map. After rebuilding
these regions the model refined smoothly to a final R-factor of
21% (outer shell=28%) for data between 12 A and 2.0 A reso-
lution (F>2o; the final R-factor for all data is 22%). The Mn2+
ion refines to a reasonable B value (26 A2), consistent with full
occupancy of the site, although it is considerably more mobile
than the metal in the Mg2+ I-domain. The final model com-
prises all non-hydrogen atoms of residues Asp132-Ala318 and
100 water molecules, and has good geometry: rms deviations
from ideality of bond lengths and bond angles of 0.017 A and
3.0° respectively. The Ramachandran plot shows that no non-
glycine main-chain dihedral angles fall in the disallowed
regions; 156 residues fall in the most favoured region, 8 in
additional allowed regions, and 2 in generously allowed
regions. These last two residues (Ser51 and Leu80) have good
electron density. No solvent correction has been applied.
Coordinates for the Mg? ' and Mn2+ I-domains have been
deposited with the Brookhaven Protein Data Bank, and are
available from the authors.
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